110 related articles for article (PubMed ID: 29723517)
21. Expression of human cytochrome P450 2B6 in Escherichia coli: characterization of catalytic activity and expression levels in human liver.
Hanna IH; Reed JR; Guengerich FP; Hollenberg PF
Arch Biochem Biophys; 2000 Apr; 376(1):206-16. PubMed ID: 10729207
[TBL] [Abstract][Full Text] [Related]
22. Modification of serine 360 by a reactive intermediate of 17-alpha-ethynylestradiol results in mechanism-based inactivation of cytochrome P450s 2B1 and 2B6.
Kent UM; Sridar C; Spahlinger G; Hollenberg PF
Chem Res Toxicol; 2008 Oct; 21(10):1956-63. PubMed ID: 18729327
[TBL] [Abstract][Full Text] [Related]
23. Roles of human CYP2A6 and 2B6 and rat CYP2C11 and 2B1 in the 10-hydroxylation of (-)-verbenone by liver microsomes.
Miyazawa M; Sugie A; Shimada T
Drug Metab Dispos; 2003 Aug; 31(8):1049-53. PubMed ID: 12867494
[TBL] [Abstract][Full Text] [Related]
24. The naturally occurring cytochrome P450 (P450) 2B6 K262R mutant of P450 2B6 exhibits alterations in substrate metabolism and inactivation.
Bumpus NN; Sridar C; Kent UM; Hollenberg PF
Drug Metab Dispos; 2005 Jun; 33(6):795-802. PubMed ID: 15769884
[TBL] [Abstract][Full Text] [Related]
25. Catalytic enhancements in cytochrome P450 2C19 by cytochrome
Lee GH; Kim V; Lee SG; Jeong E; Kim C; Lee YB; Kim D
Toxicol Res; 2024 Apr; 40(2):215-222. PubMed ID: 38525137
[TBL] [Abstract][Full Text] [Related]
26. Identification of 17-alpha-ethynylestradiol-modified active site peptides and glutathione conjugates formed during metabolism and inactivation of P450s 2B1 and 2B6.
Kent UM; Lin HL; Mills DE; Regal KA; Hollenberg PF
Chem Res Toxicol; 2006 Feb; 19(2):279-87. PubMed ID: 16485904
[TBL] [Abstract][Full Text] [Related]
27. Mechanism-based inactivation of cytochrome P450 2B6 by isoimperatorin.
Cao J; Zheng L; Ji L; Lu D; Peng Y; Zheng J
Chem Biol Interact; 2015 Jan; 226():23-9. PubMed ID: 25500267
[TBL] [Abstract][Full Text] [Related]
28. Primary role of cytochrome P450 2B6 in the oxidative metabolism of 2,2',4,4',6-pentabromodiphenyl ether (BDE-100) to hydroxylated BDEs.
Gross MS; Butryn DM; McGarrigle BP; Aga DS; Olson JR
Chem Res Toxicol; 2015 Apr; 28(4):672-81. PubMed ID: 25629761
[TBL] [Abstract][Full Text] [Related]
29. Structural Insights into the Interaction of Terpenoids with
Jeong E; Kim V; Kim C; Lee YB; Kim D
Biomol Ther (Seoul); 2024 Jul; 32(4):474-480. PubMed ID: 38835149
[No Abstract] [Full Text] [Related]
30. Mechanistic analysis of the inactivation of cytochrome P450 2B6 by phencyclidine: effects on substrate binding, electron transfer, and uncoupling.
Shebley M; Kent UM; Ballou DP; Hollenberg PF
Drug Metab Dispos; 2009 Apr; 37(4):745-52. PubMed ID: 19144770
[TBL] [Abstract][Full Text] [Related]
31. Machine Learning Models to Predict Cytochrome P450 2B6 Inhibitors and Substrates.
Li L; Lu Z; Liu G; Tang Y; Li W
Chem Res Toxicol; 2023 Aug; 36(8):1332-1344. PubMed ID: 37437120
[TBL] [Abstract][Full Text] [Related]
32. Marmoset cytochrome P450 2B6, a propofol hydroxylase expressed in liver.
Oshio T; Uehara S; Uno Y; Inoue T; Sasaki E; Yamazaki H
Xenobiotica; 2019 Mar; 49(3):265-269. PubMed ID: 29417863
[TBL] [Abstract][Full Text] [Related]
33. Mechanism-based inactivation of cytochrome P450 2B6 by isopsoralen.
Lu D; Ji L; Zheng L; Cao J; Peng Y; Zheng J
Xenobiotica; 2016; 46(4):335-41. PubMed ID: 26338349
[TBL] [Abstract][Full Text] [Related]
34. Mechanism-based inactivation of cytochromes P450 2B1 and P450 2B6 by 2-phenyl-2-(1-piperidinyl)propane.
Chun J; Kent UM; Moss RM; Sayre LM; Hollenberg PF
Drug Metab Dispos; 2000 Aug; 28(8):905-11. PubMed ID: 10901699
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of 227 drugs for in vitro inhibition of cytochrome P450 2B6.
Walsky RL; Astuccio AV; Obach RS
J Clin Pharmacol; 2006 Dec; 46(12):1426-38. PubMed ID: 17101742
[TBL] [Abstract][Full Text] [Related]
36. Functional characterization of 40 CYP2B6 allelic variants by assessing efavirenz 8-hydroxylation.
Watanabe T; Saito T; Rico EMG; Hishinuma E; Kumondai M; Maekawa M; Oda A; Saigusa D; Saito S; Yasuda J; Nagasaki M; Minegishi N; Yamamoto M; Yamaguchi H; Mano N; Hirasawa N; Hiratsuka M
Biochem Pharmacol; 2018 Oct; 156():420-430. PubMed ID: 30201214
[TBL] [Abstract][Full Text] [Related]
37. Inhibitory Effects of Garcinia cambogia Extract on CYP2B6 Enzyme Activity.
Yu JS; Choi MS; Park JS; Rehman SU; Nakamura K; Yoo HH
Planta Med; 2017 Jul; 83(11):895-900. PubMed ID: 28288493
[TBL] [Abstract][Full Text] [Related]
38. Characterization of CYP2B6 in a CYP2B6-humanized mouse model: inducibility in the liver by phenobarbital and dexamethasone and role in nicotine metabolism in vivo.
Liu Z; Li L; Wu H; Hu J; Ma J; Zhang QY; Ding X
Drug Metab Dispos; 2015 Feb; 43(2):208-16. PubMed ID: 25409894
[TBL] [Abstract][Full Text] [Related]
39. The grapefruit juice effect is not limited to cytochrome P450 (P450) 3A4: evidence for bergamottin-dependent inactivation, heme destruction, and covalent binding to protein in P450s 2B6 and 3A5.
Lin HL; Kent UM; Hollenberg PF
J Pharmacol Exp Ther; 2005 Apr; 313(1):154-64. PubMed ID: 15608076
[TBL] [Abstract][Full Text] [Related]
40. Structural and thermodynamic basis of (+)-α-pinene binding to human cytochrome P450 2B6.
Wilderman PR; Shah MB; Jang HH; Stout CD; Halpert JR
J Am Chem Soc; 2013 Jul; 135(28):10433-40. PubMed ID: 23786449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
